Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Suzhou Abogen Biosciences Co., Ltd.

Clinical trials sponsored by Suzhou Abogen Biosciences Co., Ltd., explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 4

New cancer drug targets notorious KRAS mutation in first human trial

Disease control Not yet recruiting

This is an early-stage study to test the safety and initial effects of a new drug called ABO2102 in adults with advanced solid tumors that have a specific genetic change called a KRAS mutation. The main goals are to find a safe dose and see how the body handles the drug, while al…

Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC